White label ELPA - ClinicalTrials.eu

Testing the Immune Response to Trivalent Inactivated Influenza Vaccine in People with Obesity and Type 2 Diabetes

Not yet recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
Testing Psilocybin with Therapy for Treatment of Gambling Disorder in Adults with Problem Gambling

Not yet recruiting

2 1
Investigated Drugs:
- Hypromellose
- Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
Study of Tumor-Infiltrating Lymphocyte Cell Therapy and Aldesleukin for Patients with Advanced Stage Ovarian Cancer as Initial Treatment

Not yet recruiting

1 1 1 1
Investigated Diseases:
- Ovarian cancer
Investigated Drugs:
- TIL CELLS
Long-term safety and effectiveness follow-up study of AB-1005 gene therapy in patients with Parkinson’s disease or multiple system atrophy

Not yet recruiting

3 1 1
Investigated Diseases:
- Parkinson’s disease
- Multiple system atrophy
Investigated Drugs:
A Study of Pressurized Aerosol Chemotherapy with Cisplatin and Doxorubicin for Patients with Fluid Buildup Around the Lungs Caused by Cancer

Not yet recruiting

2 1 1 1
Investigated Drugs:
- Cisplatin
- Doxorubicin Hydrochloride
Treatment of Severe Eye Chemical Burns with Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells for Patients with Severe Ocular Chemical Burns

Not yet recruiting

2 1 1 1
Investigated Drugs:
A study testing inhaled amikacin compared to placebo in critically ill patients with ventilator-associated tracheobronchitis

Not yet recruiting

3 1 1
Investigated Drugs:
- Amikacin
Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia

Not yet recruiting

3 1 1 1
Investigated Drugs:
+6
A study comparing RP2 with nivolumab versus ipilimumab with nivolumab in adults with metastatic uveal melanoma not previously treated with immune checkpoint inhibitors

Not yet recruiting

4 1 1 1
Investigated Diseases:
- Uveal melanoma
Investigated Drugs:
- RP2
- Ipilimumab
- Nivolumab
A Study Testing the Safety of CD19-Targeted CAR T-Cell Therapy in Children and Young Adults with Relapsed or Refractory B-Cell Cancers

Not yet recruiting

1 1 1
Investigated Diseases:
Investigated Drugs:
- MB-HUCART19.1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies